ARCHIVES

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

New Cancer Awards Worth $1 Million a Year Announced

September 30, 1988

Cervical Cancer Vaccine More Active In Teen Girls

February 24, 2006

Braun Named Executive Director Of ASCO Foundation

November 17, 2006

In Brief: Fred Hutchinson Center celebrates Massive Move Of 36 Labs, 400 Employees to New Campus

June 25, 1993

NCI Low Fat Diet Study For Stage 2 Breast Cancer Will Include Postmenopausal Tamxifen Therapy

September 20, 1985

Dendritic Cell Vaccine May Boost Median Survival

March 25, 2011